Covidien, a provider of patient monitoring and respiratory care devices, has acquired Newport Medical Instruments for a cash payment of approximately $108m.
Covidien has also purchased all of the capital stock of Newport Medical, pursuant to the terms of the agreement.
Newport Medical manufactures dependable, life improving ventilators for use with neonate, pediatric and adult patients.
Covidien respiratory and monitoring solutions president Robert White said, "Newport’s products and technology complement our current portfolio of respiratory solutions and will broaden our ventilation platform for patients around the world, particularly in emerging markets."
Covidien said it will include Newport Medical’s business as part of its airway & ventilation product line in the medical devices segment.